Drug intelligence / Profile preview

rose oil

Development stage: Unknown
Modality: Small Molecules
Administration: Inhalation, Topical, Oral, Per Vaginum

Overview

Rose oil, primarily derived from *Rosa damascena* (Damask rose), is an essential oil containing bioactive monoterpenoids such as geraniol, citronellol, and nerol. It is utilized for its analgesic, anti-inflammatory, anxiolytic, and antimicrobial properties. Clinical research has investigated its use in reducing dental anxiety, procedural pain, and menopausal vasomotor symptoms. Mechanistically, it modulates inflammatory cytokines (IL-6, TNF-α, IL-1β), disrupts microbial membranes, and interferes with viral adsorption (e.g., HSV-1). Additionally, components like geraniol have been shown to upregulate albumin expression, suggesting potential benefits for age-related malnutrition.

Other names: Damask rose essential oilRosa damascena oilrose essential oilTurkish rose oil

Targets

gD (HSV-2 glycoprotein D)

Beyond the preview

Go deeper on rose oil.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on rose oil.

Explore the full profile